Clinical trial

Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer

NCT00673127

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-02-01

PhasePHASE2

Study timeline

Study start (unknown)2005-02-01Date precision: month

Registry last updated2015-04-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

Ketoconazole, Hydrocortisone and DutasterideDRUG

Sponsors & collaborators

Beth Israel Deaconess Medical Centerlead sponsor

Massachusetts General Hospitalcollaborator

Dana-Farber Cancer Institutecollaborator

Sunnybrook Health Sciences Centrecollaborator

Oregon Health and Science Universitycollaborator

M.D. Anderson Cancer Centercollaborator

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkinscollaborator

Mapped research locations

BostonMassachusetts, United States3 HoustonTexas, United States1 BaltimoreMaryland, United States1 PortlandOregon, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00673127 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.